Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

被引:71
作者
Haines, David E. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha [2 ]
机构
[1] Oakland Univ, Dept Cardiovasc Med, William Beaumont Sch Med, Beaumont Hosp,Heart Rhythm Ctr, Royal Oak, MI 48073 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
complications; death; implantable cardioverter-defibrillators; outcome assessment; registries; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; PACEMAKER; OUTCOMES;
D O I
10.1161/CIRCULATIONAHA.110.959676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age >= 70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen >30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of <= 5 (8.4% of the population) to 8.4% among patients with >= 19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure. (Circulation. 2011;123:2069-2076.)
引用
收藏
页码:2069 / 2076
页数:8
相关论文
共 50 条
[31]   Implantable Cardioverter-Defibrillator for Primary Prevention in Asia [J].
Younis, Arwa ;
Wilkoff, Bruce L. .
JACC-ASIA, 2023, 3 (03) :321-334
[32]   Death with an implantable cardioverter-defibrillator: a MADIT-II substudy [J].
Chernomordik, Fernando ;
Jons, Christian ;
Klein, Helmut U. ;
Kutyifa, Valentina ;
Nof, Eyal ;
Zareba, Wojciech ;
Daubert, James P. ;
Greenberg, Henry ;
Glikson, Michael ;
Goldenberg, Ilan ;
Beinart, Roy .
EUROPACE, 2019, 21 (12) :1843-1850
[33]   Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation [J].
Healy, Christopher A. ;
Carrillo, Roger G. .
HEART RHYTHM, 2015, 12 (07) :1565-1573
[34]   Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator [J].
Looi, Khang-Li ;
Tang, Anthony ;
Agarwal, Sharad .
POSTGRADUATE MEDICAL JOURNAL, 2015, 91 (1079) :519-526
[35]   Magnetic resonance imaging in a patient with an implantable cardioverter-defibrillator [J].
Fijalkowski, Marcin ;
Mielczarek, Maksymilian ;
Szurowska, Edyta ;
Zacharek, Dariusz ;
Kempa, Maciej ;
Dorniak, Karolina ;
Bohdan, Michal ;
Sabisz, Agnieszka ;
Dubaniewicz, Miroslawa ;
Rynkiewicz, Andrzej .
KARDIOLOGIA POLSKA, 2013, 71 (06) :618-620
[36]   The extravascular implantable cardioverter-defibrillator: The pivotal study plan [J].
Crozier, Ian ;
O'Donnell, David ;
Boersma, Lucas ;
Murgatroyd, Francis ;
Manlucu, Jaimie ;
Knight, Bradley P. ;
Birgersdotter-Green, Ulrika Maria ;
Leclercq, Christophe ;
Thompson, Amy ;
Sawchuk, Robert ;
Willey, Sarah ;
Wiggenhorn, Christopher ;
Friedman, Paul .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (09) :2371-2378
[37]   Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique [J].
Francia, Pietro ;
Adduci, Carmen ;
Angeletti, Andrea ;
Ottaviano, Luca ;
Perrotta, Laura ;
De Vivo, Stefano ;
Bongiorni, Maria Grazia ;
Migliore, Federico ;
Dello Russo, Antonio ;
De Filippo, Paolo ;
Caravati, Fabrizio ;
Nigro, Gerardo ;
Palmisano, Pietro ;
Viani, Stefano ;
D'Onofrio, Antonio ;
Lovecchio, Mariolina ;
Valsecchi, Sergio ;
Ziacchi, Matteo .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (06) :1695-1703
[38]   Evolution of the Implantable Cardioverter-Defibrillator From Bullets to BBs [J].
Winkle, Roger A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) :2399-2401
[39]   Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention Cohort [J].
van Barreveld, Marit ;
Verstraelen, Tom E. ;
van Dessel, Pascal F. H. M. ;
Boersma, Lucas V. A. ;
Delnoy, Peter Paul H. M. ;
Tuinenburg, Anton E. ;
Theuns, Dominic A. M. J. ;
van der Voort, Pepijn H. ;
Kimman, Geert-Jan ;
Buskens, Erik ;
Zwinderman, Aeilko H. ;
Wilde, Arthur A. M. ;
Dijkgraaf, Marcel G. W. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (07)
[40]   Novel intravascular defibrillator: Defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model [J].
Sanders, William E., Jr. ;
Richey, Mark W. ;
Malkin, Robert A. ;
Masson, Stephen C. ;
Ransbury, T. J. ;
Urtz, Mark W. ;
Ideker, Raymond E. .
HEART RHYTHM, 2011, 8 (02) :288-292